MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma

NCT02592551 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: MEDI4736
DRUG: Tremelimumab
OTHER: no other name

Sponsor

Baylor College of Medicine